Events, By Category and Date:
» Go to news mainWhy Avoid the "M‑Word" in Human Genome Editing?
Posted by nte on
April 3, 2019
in
In Print
Baylis, F. (3 April 2019). Why avoid the "M-word" in human genome editing? Bioethics Forum – Hastings Center.
Recent News
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy
- Podcast or Perish: Episode 040: Françoise Baylis
- Bioethicist Françoise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World‑renowned Dalhousie bioethicist and battery pioneer win prestigious Killam Prize